(Q28373346)
Statements
The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase (English)
A Lucien
R Kozak
G D Lopaschuk
Identifiers
2 references
2 references